X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (171) 171
humans (166) 166
oncology (119) 119
melanoma (95) 95
female (73) 73
male (69) 69
melanoma - immunology (64) 64
article (62) 62
middle aged (60) 60
surgery (56) 56
melanoma - pathology (55) 55
peptides (55) 55
immunology (54) 54
immunotherapy (51) 51
human necessities (45) 45
hygiene (45) 45
medical or veterinary science (45) 45
adult (41) 41
aged (41) 41
skin neoplasms - pathology (40) 40
cancer (39) 39
metastatic melanoma (37) 37
preparations for medical, dental, or toilet purposes (37) 37
chemistry (36) 36
metallurgy (36) 36
organic chemistry (36) 36
melanoma - therapy (35) 35
medicine, research & experimental (34) 34
t-lymphocytes, cytotoxic - immunology (33) 33
malignant-melanoma (32) 32
microbiology (32) 32
prognosis (32) 32
abridged index medicus (31) 31
biochemistry (31) 31
beer (30) 30
compositions thereof (30) 30
culture media (30) 30
enzymology (30) 30
microorganisms or enzymes (30) 30
mutation or genetic engineering (30) 30
propagating, preserving or maintaining microorganisms (30) 30
spirits (30) 30
vinegar (30) 30
wine (30) 30
neoplasm staging (29) 29
cancer vaccines - immunology (28) 28
dendritic cells (26) 26
antigens, neoplasm - immunology (25) 25
melanoma - mortality (25) 25
t cells (24) 24
medicine & public health (22) 22
aged, 80 and over (21) 21
skin neoplasms - immunology (21) 21
amino acid sequence (20) 20
expression (20) 20
melanoma - metabolism (20) 20
metastasis (20) 20
vaccines (20) 20
identification (19) 19
antigens (18) 18
cell line, tumor (18) 18
colony-stimulating factor (18) 18
follow-up studies (18) 18
health aspects (18) 18
melanoma - drug therapy (18) 18
neoplasm proteins - immunology (18) 18
tumor-infiltrating lymphocytes (18) 18
vaccination (18) 18
cancer vaccines (17) 17
clinical trials (17) 17
research (17) 17
time factors (17) 17
treatment outcome (17) 17
cancer vaccines - administration & dosage (16) 16
human (16) 16
melanoma - genetics (16) 16
melanoma - secondary (16) 16
melanoma - surgery (16) 16
peptide vaccine (16) 16
skin neoplasms - mortality (16) 16
tumor cells, cultured (16) 16
analysis (15) 15
animals (15) 15
lymphatic metastasis (15) 15
survival (15) 15
dermatology (14) 14
diagnosis (14) 14
medical research (14) 14
medicine (14) 14
molecular sequence data (14) 14
peptide fragments - immunology (14) 14
phase-ii trial (14) 14
survival rate (14) 14
tumors (14) 14
united states (14) 14
cancer research (13) 13
enzymes (13) 13
peptides - immunology (13) 13
skin neoplasms - surgery (13) 13
biopsy (12) 12
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (342) 342
French (23) 23
German (8) 8
Finnish (2) 2
Swedish (2) 2
Norwegian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Surgery, ISSN 0039-6060, 09/2019, Volume 166, Issue 3, pp. 322 - 326
Obesity is a risk factor for colorectal cancer and possibly the formation of precancerous, colorectal polyps . Bariatric surgery is very effective for... 
SURGERY | GASTRIC BYPASS | RISK | OBESITY | OUTCOMES | CANCER INCIDENCE | Obesity | Comorbidity | Surgery | Analysis | Colorectal cancer | College teachers | Health aspects | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Methods in Enzymology, ISSN 0076-6879, 2019
In a variety of solid tumors, the presence of higher densities of tumor-infiltrating lymphocytes or tertiary lymphoid structures (TLS) are correlated with... 
Immunology | Tumor infiltrating lymphocytes | IHC | Multiplex immunohistochemistry | Tertiary lymphoid structures | Glioblastoma | Melanoma
Journal Article
Journal of immunology (Baltimore, Md. : 1950), ISSN 0022-1767, 1/2018, Volume 200, Issue 2, pp. 432 - 442
Limited representation of intratumoral immune cells is a major barrier to tumor control. However, simply enhancing immune responses in tumor-draining lymph... 
Journal Article
Journal of the American College of Surgeons, ISSN 1072-7515, 2014, Volume 218, Issue 4, pp. 528 - 529
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 01/2019, Volume 119, Issue 2, pp. 222 - 231
Journal Article
Journal Article
Statistics in Biosciences, ISSN 1867-1764, 06/2019
Journal Article
Journal of hematology & oncology, ISSN 1756-8722, 10/2017, Volume 10, Issue 1, pp. 160 - 160
The original article [1] contained an error in Fig. 1 mistakenly carried forward by the Production team handling this article whereby the values denoting the... 
Gene expression | Melanoma
Journal Article
Cell, ISSN 0092-8674, 11/2017, Volume 171, Issue 4, pp. 934 - 949.e16
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 1780 - 1780
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2015, Volume 137, Issue 6, pp. 1386 - 1396
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 3638 - 3638
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 06/2015, Volume 111, Issue 7, pp. 800 - 807
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 01/2017, Volume 66, Issue 1, p. 33
  Introduction Infiltration of non-small-cell lung cancer (NSCLC) by CD8+ T lymphocytes predicts improved patient survival; however, heterogeneity of... 
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 01/2017, Volume 66, Issue 1, p. 33
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00262-016-1908-4... 
T cells | Comparative analysis | Lung cancer, Non-small cell | Tumors
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 01/2017, Volume 66, Issue 1, pp. 33 - 43
Infiltration of non-small-cell lung cancer (NSCLC) by CD8 super(+) T lymphocytes predicts improved patient survival; however, heterogeneity of intratumoral... 
Journal Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 12/2019, Volume 7, Issue 1, pp. 1 - 13
Abstract Background Cancer vaccines require adjuvants to induce effective immune responses; however, there is no consensus on optimal adjuvants. We... 
Lipopolysaccharide | polyICLC | Peptide vaccine | Incomplete freund’s adjuvant | Toll-like receptor | Melanoma
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.